A recent study suggested that the p.P522R variant may maintain cognitive function during aging by mitigating the accumulation of toxic tau pathology in the brain, when this co-occurs with the accumulation of amyloid pathology, both hallmarks of Alzheimer’s disease [19]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.